Search results
BCIS ACI 2025
Start date:
Jan 29, 2025
End date:
Jan 31, 2025
Event
Author(s):
Babar Basir
,
Balimkiz Senman
,
Jacob E Møller
Added:
1 year ago
In this insightful webinar, Dr Babar Basir (Henry Ford Heart and Vascular Institute, Detroit, MI, US) is joined by Dr Balimkiz Senman (Duke University Hospital, Boston, MA, US) and Prof Jacob Møller (Odense University Hospital, Odense, DE) to delve into the findings of the DanGer Shock trial, recently presented at the American College of Cardiology (ACC) Conference in April 2024. This session…
View more
Author(s):
Dipti Itchhaporia
Added:
1 year ago
ACC 2025 - In this succinct video, Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute & University of California, CA, US) outlines the key late-breaking trials from the conference that are expected to have an impact on clinical practice.Trials covered in detail include:FRESH-UPAPI-CATALIGN-ARPROTECT-TAVIRecorded on-site at ACC in Chicago, 2025.Support: This is an independent interview…
View more
Arunima Misra
Research Area(s) / Expertise:
Job title: Associate Professor, Section of Cardiology
Author
Author(s):
Sara Saberi
Added:
7 months ago
Master the diagnostic complexities of hypertrophic cardiomyopathy (HCM) with Dr Sara Saberi, a leading expert in inherited cardiovascular diseases.This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, provides essential insights into the nuanced approach required for accurate HCM diagnosis and risk stratification.Dr Saberi…
View more
Author(s):
Frederick Welt
Added:
7 months ago
Learn about haemodynamic guidance in cardiogenic shock, including early intervention, device selection, and exit strategies, from Dr Frederick Welt (University of Utah, US)This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr…
View more
Added:
6 months ago
Source:
Radcliffe Cardiology
Differentiating cardiac amyloidosis (CA) from its phenotypic mimics remains a clinical challenge. A new study published in the European Heart Journal details the development and validation of a novel artificial intelligence (AI) model that can accurately screen for CA using only a single apical four-chamber echocardiogram video clip.¹This retrospective, multisite, multiethnic study first trained…
View more
Jeremy A Mazurek
Research Area(s) / Expertise:
Author
Author(s):
Milind Y Desai
Added:
1 year ago
AHA Conference 2024 - 128-week results of VALOR-HCM investigating mavacamten treatment for patients with hypertrophic cardiomyopathy (HCM) referred for septal reduction therapy (SRT) procedures.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at AHA Conference to discuss the findings from VALOR-HCM (NCT04349072).VALOR-HCM is a randomized, double-blind, placebo-controlled, phase 3…
View more
Cardiomyopathy and Gender Disparities in South Asia
Author(s):
Khalida Soomro
,
David Tak Wai Lui
,
Rungroj Krittayaphong
,
et al
Added:
5 months ago
Review Article